Browse CATs

Browse CATs  internal medicine  pulmonary medicine  community-acquired pneumonia

Diagnosis Harm/ aetiology Prognosis Therapy

Community-acquired pneumonia multilobar: no clear benefit from filgrastim Level of evidence 1b- Expiry Date October 2003 Community-acquired pneumonia oral antibiotics are as effective as intravenous for uncomplicated cases Level of evidence 1b Expiry Date March 2003 Community-acquired pneumonia some antibiotic regimens saved more lives in elderly patients. Level of evidence 2b Expiry Date March 2003 Community-acquired pneumonia levofloxacin increased clinical success. Level of evidence 1b Expiry Date March 2003 Community-acquired pneumonia 23-valent pneumococcal capsular polysaccharide vaccine had no clear effect. Level of evidence 1b- Expiry Date March 2003 Community-acquired pneumonia pneumococcal vaccine decreases pneumococcal pneumonia. Level of evidence 1a Expiry Date March 2003 Community-acquired pneumonia combined pneumococcal/influenza vaccinations were no better than influenza alone. Level of evidence 1b- Expiry Date March 2003 Community-acquired pneumonia sparfloxacin decreased early relapse. Level of evidence 1b Expiry Date March 2003 Influenza vaccination caused few adverse effects except sore arms Level of evidence 1b Expiry Date November 2003  Pleural effusion infection: streptokinase and urokinase were probably equally as effective. Level of evidence 1b Expiry Date April 2003 Pleuritic pain reduced by indomethacin. Level of evidence 1b Expiry Date September 2003 Pneumonia combined live and inactivated influenza A vaccines decreased cases. Level of evidence 1b Expiry Date March 2003 Pneumonia Influenza vaccination reduced death and hospitalisation in elderly patients Level of evidence 2a Expiry Date March 2003 Pleural effusion infection: streptokinase helped drainage. Level of evidence 1b Expiry Date April 2003